Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
13,625.00    95.00 (0.70%)
Bid:
13,580.00
Ask:
13,590.00
Spread: 10.00 (0.074%)
Market Cap: £15.55b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Trading Statement

30 Oct 2024 07:00

RNS Number : 1232K
Next PLC
30 October 2024
Β 

Trading Statement - 30 October 2024

HEADLINES

Β·

Full price1 sales in the third quarter (August - October) were up +7.6% versus last year. This was +2.6% ahead of our guidance for the quarter of +5.0%.

Β·

We believe the strong performance was driven by the early arrival of colder weather this year, versus an unusually warm September and early October last year.

Β·

We are increasing guidance for Q4 full price sales growth by +1.0%, to +3.5% (see analysis below).

Β·

The improved sales in Q3 along with our forecast for Q4 add Β£43m to full price sales and Β£10m to profit; accordingly we are upgrading our profit2 guidance for the full year from Β£995m to Β£1,005m.

1 Full price sales include all items sold in NEXT Retail, NEXT Online including third-party brands, and NEXT Finance interest income, but excludes Sale events, Clearance, Total Platform commission and subsidiaries' sales.Β 

2 NEXT Group profit before tax excludes: (1) the cost of brand amortisation, (2) the profit attributable to shares that we do not own in subsidiary companies, and (3) an exceptional, non-cash, loss relating to the closure of our defined benefit pension scheme.

FULL PRICE SALES PERFORMANCE

Full price sales performance by business division is set out below. Variances to last year are shown for the third quarter and the year to date.

Full price sales by division versus last year

Q3: 13 weeks

to 26 October

Year to

26 October

Online NEXT UK

+7.8%

+4.2%

Online LABEL UK

+8.0%

+6.0%

Total Online UK

+7.9%

+4.9%

Retail

+2.9%

- 0.8%

Total UK

+5.8%

+2.4%

Online Overseas

+20.4%

+22.0%

Total Product full price sales

+8.1%

+5.6%

NEXT Finance interest income

+0.0%

+3.2%

Total full price sales

+7.6%

+5.5%

Β 

Q4 FULL PRICE SALES GUIDANCE

The chart below shows our full price sales performance against last year (blue bar) and against two years ago (dotted line). As shown, our Q4 forecast against last year looks pessimistic, but is much more realistic when compared with two years ago. We are more confident in the two year comparison as we believe the overperformance in Q3 this year is likely to have pulled forward sales from Q4.

GUIDANCE FOR FULL YEAR SALES, PROFIT AND EARNINGS PER SHARE

Our revised guidance for sales, profit and Earnings Per Share for the full year is summarised below. For completeness, our previous guidance is shown in grey.

New guidance

Previous guidance

Guidance for the full year 2024/25

Full year

Β£ (e)

% Versus

2023/24

Full year

Β£ (e)

% Versus

2023/24

Full price sales

Β£5.02bn

+4.9%

Β£4.98bn

+4.0%

Total Group sales3

(inc. markdown, subsidiaries and investments)

Β£6.27bn

+7.4%

Β£6.23bn

+6.6%

NEXT Group profit before tax

Β£1,005m

+9.5%

Β£995m

+8.4%

Pre-tax EPS

839.3p

+10.8%

830.4p

+9.7%

Post-tax EPS

632.4p

+9.3%

625.7p

+8.1%

3. Total Group sales are the sum of total sales (full price and markdown) from all of the Group's divisions plus revenue from subsidiary companies. Subsidiaries' turnover is calculated using our share of our subsidiaries' turnover. For example, we own 74% of Joules so we include 74% of their sales in our top line.

Total Group sales for the full year are expected to be up +7.4% on last year, which is +2.5% higher than our expected growth in full price sales of +4.9%. The difference is the result of acquisitions completed during the last year. We acquired 97% of FatFace in October 2023 and increased our equity share in Reiss in September 2023 and June 2024; we now have a 74% shareholding in Reiss.

CHRISTMAS TRADING STATEMENT

We are scheduled to give an update on sales to Saturday 28 December, on Tuesday 7 January 2025.

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

Β 

Β 

Β 

Date:

Embargoed until 07:00 hrs, Wednesday 30 October 2024

Contacts:

Jonathan Blanchard, Chief Financial Officer (analyst calls)

Β 

NEXT PLC

Tel: 0333 777 8888

Β 

Alistair Mackinnon-Musson

Email: next@rowbellpr.com

Β 

Rowbell PR

Tel: 020 7717 5239

Photographs:

https://www.nextplc.co.uk/media/image-gallery/campaign-images

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTVKLFLZBLLFBF
Date   Source Headline
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement
1st Aug 20238:34 amRNSTotal Voting Rights
12th Jul 20235:08 pmRNSTransaction in Own Shares
11th Jul 20235:46 pmRNSTransaction in Own Shares
10th Jul 20235:14 pmRNSTransaction in Own Shares
7th Jul 20235:10 pmRNSTransaction in Own Shares
6th Jul 20235:44 pmRNSTransaction in Own Shares
5th Jul 20235:43 pmRNSTransaction in Own Shares
4th Jul 20235:18 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.